The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
VJVirtual | Early vs. deferred transplantation in AL amyloidosis
Surbhi Sidana
• 1 Jun 2020
Surbhi Sidana, MD, Mayo Clinic, Stanford, CA, compares early versus deferred stem-cell transplantation for amyloid light-chain (AL) amyloidosis patients, as evaluated in a retrospective study comparing overall survival between patients who proceed directly to autologous stem cell transplant after stem cell collection and those who defer. This interview was recorded via an online conference call with the Video Journal of Hematological Oncology (VJHemOnc).
